

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | glycosphingolipid catabolic process (GO:0046479) | 4.57388237 |
| 2 | response to peptidoglycan (GO:0032494) | 4.31011906 |
| 3 | neutrophil activation involved in immune response (GO:0002283) | 4.22266129 |
| 4 | glycolipid catabolic process (GO:0019377) | 4.17977685 |
| 5 | positive regulation by symbiont of host defense response (GO:0052509) | 4.07335438 |
| 6 | modulation by symbiont of host defense response (GO:0052031) | 4.07335438 |
| 7 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.07335438 |
| 8 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.07335438 |
| 9 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.07335438 |
| 10 | modulation by symbiont of host immune response (GO:0052553) | 4.07335438 |
| 11 | macrophage activation involved in immune response (GO:0002281) | 3.92085365 |
| 12 | oligosaccharide catabolic process (GO:0009313) | 3.89245639 |
| 13 | negative regulation of interleukin-12 production (GO:0032695) | 3.86997980 |
| 14 | drug catabolic process (GO:0042737) | 3.80316455 |
| 15 | detection of molecule of bacterial origin (GO:0032490) | 3.77463826 |
| 16 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.68295265 |
| 17 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.68002482 |
| 18 | cellular response to thyroid hormone stimulus (GO:0097067) | 3.64425550 |
| 19 | ceramide catabolic process (GO:0046514) | 3.59144831 |
| 20 | intestinal cholesterol absorption (GO:0030299) | 3.57915302 |
| 21 | detection of other organism (GO:0098543) | 3.55057545 |
| 22 | regulation of mast cell degranulation (GO:0043304) | 3.53401863 |
| 23 | protein localization to endosome (GO:0036010) | 3.52033187 |
| 24 | regulation of leukocyte degranulation (GO:0043300) | 3.50721717 |
| 25 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.42035062 |
| 26 | L-phenylalanine catabolic process (GO:0006559) | 3.42035062 |
| 27 | phospholipid efflux (GO:0033700) | 3.38960288 |
| 28 | detection of external biotic stimulus (GO:0098581) | 3.38562473 |
| 29 | positive regulation of leukocyte degranulation (GO:0043302) | 3.38296957 |
| 30 | exogenous drug catabolic process (GO:0042738) | 3.33571098 |
| 31 | L-phenylalanine metabolic process (GO:0006558) | 3.29321969 |
| 32 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.29321969 |
| 33 | amino sugar catabolic process (GO:0046348) | 3.29277629 |
| 34 | barbed-end actin filament capping (GO:0051016) | 3.26916045 |
| 35 | negative regulation of cell killing (GO:0031342) | 3.23726495 |
| 36 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.23726495 |
| 37 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 3.20991037 |
| 38 | urea metabolic process (GO:0019627) | 3.20186378 |
| 39 | urea cycle (GO:0000050) | 3.20186378 |
| 40 | regulation of mononuclear cell migration (GO:0071675) | 3.19977568 |
| 41 | regulation of mast cell activation involved in immune response (GO:0033006) | 3.19197589 |
| 42 | detection of bacterium (GO:0016045) | 3.18017987 |
| 43 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.17592599 |
| 44 | cellular extravasation (GO:0045123) | 3.16956963 |
| 45 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.15780720 |
| 46 | synaptic vesicle maturation (GO:0016188) | 3.15131504 |
| 47 | regulation of macrophage chemotaxis (GO:0010758) | 3.14344654 |
| 48 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.13804852 |
| 49 | membrane lipid catabolic process (GO:0046466) | 3.13242922 |
| 50 | high-density lipoprotein particle remodeling (GO:0034375) | 3.10556443 |
| 51 | sodium ion export (GO:0071436) | 3.09015014 |
| 52 | intestinal absorption (GO:0050892) | 3.06531902 |
| 53 | cholesterol efflux (GO:0033344) | 3.05663577 |
| 54 | sphingolipid catabolic process (GO:0030149) | 3.05133746 |
| 55 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.04721185 |
| 56 | peptide catabolic process (GO:0043171) | 3.04347999 |
| 57 | reverse cholesterol transport (GO:0043691) | 3.02100459 |
| 58 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.01775698 |
| 59 | cellular potassium ion homeostasis (GO:0030007) | 3.01145977 |
| 60 | aromatic amino acid family catabolic process (GO:0009074) | 2.99098236 |
| 61 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.99003865 |
| 62 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.98085347 |
| 63 | positive regulation of mast cell degranulation (GO:0043306) | 2.98085347 |
| 64 | adhesion of symbiont to host cell (GO:0044650) | 2.97380832 |
| 65 | virion attachment to host cell (GO:0019062) | 2.97380832 |
| 66 | regulation of regulated secretory pathway (GO:1903305) | 2.96049856 |
| 67 | mannose metabolic process (GO:0006013) | 2.95185389 |
| 68 | regulation of cholesterol homeostasis (GO:2000188) | 2.95077516 |
| 69 | response to thyroid hormone (GO:0097066) | 2.93356906 |
| 70 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.93277788 |
| 71 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.93202352 |
| 72 | protein carboxylation (GO:0018214) | 2.93202352 |
| 73 | regulation of macrophage cytokine production (GO:0010935) | 2.91471078 |
| 74 | detection of biotic stimulus (GO:0009595) | 2.90745112 |
| 75 | granulocyte activation (GO:0036230) | 2.88725802 |
| 76 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.87384318 |
| 77 | macrophage activation (GO:0042116) | 2.87378233 |
| 78 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.87376921 |
| 79 | positive regulation of mast cell activation (GO:0033005) | 2.87215106 |
| 80 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.87209791 |
| 81 | nitrogen cycle metabolic process (GO:0071941) | 2.85761188 |
| 82 | negative regulation of sterol transport (GO:0032372) | 2.85397269 |
| 83 | negative regulation of cholesterol transport (GO:0032375) | 2.85397269 |
| 84 | response to laminar fluid shear stress (GO:0034616) | 2.84863769 |
| 85 | alpha-linolenic acid metabolic process (GO:0036109) | 2.84584464 |
| 86 | N-acetylneuraminate metabolic process (GO:0006054) | 2.84052878 |
| 87 | lysine metabolic process (GO:0006553) | 2.82249163 |
| 88 | lysine catabolic process (GO:0006554) | 2.82249163 |
| 89 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.81956724 |
| 90 | drug transmembrane transport (GO:0006855) | 2.81189774 |
| 91 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.80439109 |
| 92 | response to host immune response (GO:0052572) | 2.80439109 |
| 93 | immunoglobulin mediated immune response (GO:0016064) | 2.79379551 |
| 94 | regulation of cholesterol esterification (GO:0010872) | 2.76966204 |
| 95 | positive regulation of myeloid leukocyte mediated immunity (GO:0002888) | 2.76358040 |
| 96 | regulation of early endosome to late endosome transport (GO:2000641) | 2.75138504 |
| 97 | T-helper 1 type immune response (GO:0042088) | 2.74654552 |
| 98 | pinocytosis (GO:0006907) | 2.72673070 |
| 99 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.72199909 |
| 100 | glutamate secretion (GO:0014047) | 2.71239434 |
| 101 | neutrophil activation (GO:0042119) | 2.69614232 |
| 102 | plasma lipoprotein particle assembly (GO:0034377) | 2.69025098 |
| 103 | kynurenine metabolic process (GO:0070189) | 2.68821448 |
| 104 | indole-containing compound catabolic process (GO:0042436) | 2.68074064 |
| 105 | indolalkylamine catabolic process (GO:0046218) | 2.68074064 |
| 106 | tryptophan catabolic process (GO:0006569) | 2.68074064 |
| 107 | plasma lipoprotein particle remodeling (GO:0034369) | 2.67679636 |
| 108 | protein-lipid complex remodeling (GO:0034368) | 2.67679636 |
| 109 | macromolecular complex remodeling (GO:0034367) | 2.67679636 |
| 110 | positive regulation of regulated secretory pathway (GO:1903307) | 2.67672138 |
| 111 | cysteine metabolic process (GO:0006534) | 2.67047082 |
| 112 | cellular modified amino acid catabolic process (GO:0042219) | 2.66933296 |
| 113 | adhesion of symbiont to host (GO:0044406) | 2.66767126 |
| 114 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.66729159 |
| 115 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.66642795 |
| 116 | phospholipid homeostasis (GO:0055091) | 2.66422077 |
| 117 | negative regulation of toll-like receptor 4 signaling pathway (GO:0034144) | 2.64577885 |
| 118 | glutamate metabolic process (GO:0006536) | 2.64163340 |
| 119 | regulation of triglyceride catabolic process (GO:0010896) | 2.64028812 |
| 120 | response to host (GO:0075136) | 2.63489383 |
| 121 | response to host defenses (GO:0052200) | 2.63489383 |
| 122 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.63489383 |
| 123 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.63259626 |
| 124 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.62605005 |
| 125 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.62202006 |
| 126 | protein-lipid complex assembly (GO:0065005) | 2.61645915 |
| 127 | tryptophan metabolic process (GO:0006568) | 2.61202224 |
| 128 | neurotransmitter secretion (GO:0007269) | 2.60224068 |
| 129 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.60185723 |
| 130 | positive regulation of macrophage cytokine production (GO:0060907) | 2.59575494 |
| 131 | regulation of mast cell activation (GO:0033003) | 2.58027909 |
| 132 | synaptic vesicle exocytosis (GO:0016079) | 2.57864305 |
| 133 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.57059804 |
| 134 | detection of temperature stimulus involved in sensory perception (GO:0050961) | 2.56941319 |
| 135 | detection of temperature stimulus involved in sensory perception of pain (GO:0050965) | 2.56941319 |
| 136 | positive regulation of lipid catabolic process (GO:0050996) | 2.56848131 |
| 137 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.55528332 |
| 138 | regulation of monocyte chemotaxis (GO:0090025) | 2.55179047 |
| 139 | myeloid cell activation involved in immune response (GO:0002275) | 2.54319621 |
| 140 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.53487956 |
| 141 | apoptotic cell clearance (GO:0043277) | 2.48653939 |
| 142 | locomotory exploration behavior (GO:0035641) | 2.48395551 |
| 143 | stress fiber assembly (GO:0043149) | 2.47835954 |
| 144 | gamma-aminobutyric acid transport (GO:0015812) | 2.45524127 |
| 145 | microglial cell activation (GO:0001774) | 2.44657288 |
| 146 | glyoxylate metabolic process (GO:0046487) | 2.44560428 |
| 147 | regulation of synaptic vesicle exocytosis (GO:2000300) | 2.44358256 |
| 148 | positive regulation of monocyte chemotaxis (GO:0090026) | 2.44136543 |
| 149 | regulation of cholesterol storage (GO:0010885) | 2.43925749 |
| 150 | sulfur amino acid catabolic process (GO:0000098) | 2.43290141 |
| 151 | detection of temperature stimulus (GO:0016048) | 2.41881155 |
| 152 | cellular ketone body metabolic process (GO:0046950) | 2.40601827 |
| 153 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.40571246 |
| 154 | cell communication involved in cardiac conduction (GO:0086065) | 2.40379456 |
| 155 | regulation of superoxide anion generation (GO:0032928) | 2.40096001 |
| 156 | response to muramyl dipeptide (GO:0032495) | 2.40085582 |
| 157 | regulation of ARF protein signal transduction (GO:0032012) | 2.39627931 |
| 158 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.39611334 |
| 159 | positive regulation of receptor recycling (GO:0001921) | 2.39314219 |
| 160 | regulation of vitamin metabolic process (GO:0030656) | 2.38765574 |
| 161 | bile acid biosynthetic process (GO:0006699) | 2.38641309 |
| 162 | angiotensin maturation (GO:0002003) | 2.37297447 |
| 163 | vocalization behavior (GO:0071625) | 2.37088949 |
| 164 | * alanine transport (GO:0032328) | 2.36821522 |
| 165 | drug transport (GO:0015893) | 2.36699288 |
| 166 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.35969110 |
| 167 | respiratory burst (GO:0045730) | 2.35604480 |
| 168 | germinal center formation (GO:0002467) | 2.35152702 |
| 169 | complement activation, alternative pathway (GO:0006957) | 2.35128264 |
| 170 | flavonoid metabolic process (GO:0009812) | 2.35050852 |
| 171 | nucleobase catabolic process (GO:0046113) | 2.34914562 |
| 172 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.34179672 |
| 173 | lipoprotein metabolic process (GO:0042157) | 2.34001378 |
| 174 | coenzyme catabolic process (GO:0009109) | 2.33990188 |
| 175 | * proline transport (GO:0015824) | 2.33312652 |
| 176 | bile acid and bile salt transport (GO:0015721) | 2.32224345 |
| 177 | regulation of protein activation cascade (GO:2000257) | 2.32211989 |
| 178 | activation of protein kinase A activity (GO:0034199) | 2.30656440 |
| 179 | homocysteine metabolic process (GO:0050667) | 2.29578251 |
| 180 | cellular sodium ion homeostasis (GO:0006883) | 2.29042289 |
| 181 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.28723016 |
| 182 | lipoprotein transport (GO:0042953) | 2.28697146 |
| 183 | plasma lipoprotein particle clearance (GO:0034381) | 2.27974219 |
| 184 | plasma lipoprotein particle organization (GO:0071827) | 2.26945817 |
| 185 | cholesterol transport (GO:0030301) | 2.26866660 |
| 186 | sterol transport (GO:0015918) | 2.26866660 |
| 187 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.26855672 |
| 188 | protein-lipid complex subunit organization (GO:0071825) | 2.25375922 |
| 189 | macroautophagy (GO:0016236) | 2.22909508 |
| 190 | bile acid metabolic process (GO:0008206) | 2.21313989 |
| 191 | regulation of complement activation (GO:0030449) | 2.19535787 |
| 192 | membrane depolarization during action potential (GO:0086010) | 2.19104042 |
| 193 | triglyceride homeostasis (GO:0070328) | 2.18782093 |
| 194 | acylglycerol homeostasis (GO:0055090) | 2.18782093 |
| 195 | regulation of synaptic vesicle transport (GO:1902803) | 2.18215347 |
| 196 | sterol homeostasis (GO:0055092) | 2.17785548 |
| 197 | amino-acid betaine metabolic process (GO:0006577) | 2.16875376 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.01083596 |
| 2 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 3.27882783 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.10434971 |
| 4 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.05151125 |
| 5 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.01269155 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.98533734 |
| 7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.78013572 |
| 8 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.62763794 |
| 9 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.58094698 |
| 10 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.57484313 |
| 11 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.36407590 |
| 12 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.34484377 |
| 13 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.27585723 |
| 14 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.14361270 |
| 15 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.08549757 |
| 16 | GATA1_22025678_ChIP-Seq_K562_Human | 2.01198956 |
| 17 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.00499156 |
| 18 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.96738628 |
| 19 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.93005760 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.92573114 |
| 21 | EZH2_22144423_ChIP-Seq_EOC_Human | 1.87752644 |
| 22 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.85675881 |
| 23 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.82676956 |
| 24 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 1.77101374 |
| 25 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.76564010 |
| 26 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.76317985 |
| 27 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.76251411 |
| 28 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.75626958 |
| 29 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.75114337 |
| 30 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.70109347 |
| 31 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 1.69972996 |
| 32 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.67539460 |
| 33 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.66959091 |
| 34 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.66509252 |
| 35 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.63406677 |
| 36 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.60843232 |
| 37 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58203719 |
| 38 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.57907317 |
| 39 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.55208259 |
| 40 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.54038890 |
| 41 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.54038890 |
| 42 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.53317085 |
| 43 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.53305126 |
| 44 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.52869456 |
| 45 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.48875166 |
| 46 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.48342505 |
| 47 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.48196929 |
| 48 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.47855617 |
| 49 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.45857961 |
| 50 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.45704889 |
| 51 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.45375464 |
| 52 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.43468260 |
| 53 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.42601873 |
| 54 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.41656650 |
| 55 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.38401389 |
| 56 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.38108439 |
| 57 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.38089616 |
| 58 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.37964463 |
| 59 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.36997940 |
| 60 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.33394723 |
| 61 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.33119502 |
| 62 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.31910673 |
| 63 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31733575 |
| 64 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 1.31406600 |
| 65 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.31381072 |
| 66 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.31127001 |
| 67 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.29717874 |
| 68 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28416612 |
| 69 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.27570521 |
| 70 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.27014421 |
| 71 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.26860789 |
| 72 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.25542142 |
| 73 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.25204087 |
| 74 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.24266180 |
| 75 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.23645767 |
| 76 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.23156486 |
| 77 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.23091270 |
| 78 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.22931936 |
| 79 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.22709652 |
| 80 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.21925561 |
| 81 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.21165481 |
| 82 | MAF_26560356_Chip-Seq_TH1_Human | 1.18695915 |
| 83 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18068092 |
| 84 | MYC_22102868_ChIP-Seq_BL_Human | 1.16927406 |
| 85 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.16564088 |
| 86 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.16206216 |
| 87 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.16202750 |
| 88 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.15720603 |
| 89 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.15610758 |
| 90 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.13414687 |
| 91 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.13275406 |
| 92 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.10528206 |
| 93 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.10338084 |
| 94 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10058147 |
| 95 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.10045821 |
| 96 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.10028956 |
| 97 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.09562572 |
| 98 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.08932579 |
| 99 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.08830219 |
| 100 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.08445558 |
| 101 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.07842632 |
| 102 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07452384 |
| 103 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07423363 |
| 104 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.06314983 |
| 105 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06106229 |
| 106 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.04298190 |
| 107 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.03777985 |
| 108 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.03297685 |
| 109 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.03132122 |
| 110 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.03034018 |
| 111 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.02684911 |
| 112 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.00553330 |
| 113 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99735528 |
| 114 | UTX_26944678_Chip-Seq_JUKART_Human | 0.98631657 |
| 115 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.98389259 |
| 116 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98357182 |
| 117 | SMAD4_21799915_ChIP-Seq_A2780_Human | 0.98007840 |
| 118 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97632813 |
| 119 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96348422 |
| 120 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.96017171 |
| 121 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.96015365 |
| 122 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95386191 |
| 123 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.95235710 |
| 124 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.94628637 |
| 125 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.94226439 |
| 126 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.93542643 |
| 127 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.93328278 |
| 128 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.92985720 |
| 129 | SPI1_23127762_ChIP-Seq_K562_Human | 0.91672692 |
| 130 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.91298041 |
| 131 | * ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.91253822 |
| 132 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.90716489 |
| 133 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.90132046 |
| 134 | GATA1_19941826_ChIP-Seq_K562_Human | 0.90066019 |
| 135 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.89988411 |
| 136 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 0.89632969 |
| 137 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.89252162 |
| 138 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.88409905 |
| 139 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.88313246 |
| 140 | AR_19668381_ChIP-Seq_PC3_Human | 0.86813668 |
| 141 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.86410062 |
| 142 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.85904083 |
| 143 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.84900371 |
| 144 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83854005 |
| 145 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.83632526 |
| 146 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.82835209 |
| 147 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.82701399 |
| 148 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 0.82655220 |
| 149 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 0.82610138 |
| 150 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 0.82522145 |
| 151 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 0.82513265 |
| 152 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 0.82264143 |
| 153 | RXR_22108803_ChIP-Seq_LS180_Human | 0.82159565 |
| 154 | TP53_16413492_ChIP-PET_HCT116_Human | 0.82136038 |
| 155 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 0.80117407 |
| 156 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.79514031 |
| 157 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 0.77839010 |
| 158 | * AR_25329375_ChIP-Seq_VCAP_Human | 0.77733219 |
| 159 | KDM2B_26808549_Chip-Seq_DND41_Human | 0.77703467 |
| 160 | STAT3_23295773_ChIP-Seq_U87_Human | 0.77381802 |
| 161 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.77335689 |
| 162 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.77068954 |
| 163 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.76953844 |
| 164 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.76329651 |
| 165 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.76162456 |
| 166 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.74468808 |
| 167 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.74270024 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005360_urolithiasis | 5.41940409 |
| 2 | MP0002139_abnormal_hepatobiliary_system | 4.33698999 |
| 3 | MP0005085_abnormal_gallbladder_physiolo | 3.53072986 |
| 4 | MP0004859_abnormal_synaptic_plasticity | 3.12964443 |
| 5 | MP0003436_decreased_susceptibility_to | 3.12405785 |
| 6 | MP0002822_catalepsy | 3.08957960 |
| 7 | MP0005365_abnormal_bile_salt | 3.00442267 |
| 8 | MP0006082_CNS_inflammation | 2.86785539 |
| 9 | MP0004858_abnormal_nervous_system | 2.69767800 |
| 10 | MP0001968_abnormal_touch/_nociception | 2.68595426 |
| 11 | MP0008875_abnormal_xenobiotic_pharmacok | 2.68161470 |
| 12 | MP0009840_abnormal_foam_cell | 2.60581603 |
| 13 | MP0002735_abnormal_chemical_nociception | 2.55145734 |
| 14 | MP0003252_abnormal_bile_duct | 2.52848358 |
| 15 | MP0003724_increased_susceptibility_to | 2.48505813 |
| 16 | MP0005451_abnormal_body_composition | 2.47877386 |
| 17 | MP0004270_analgesia | 2.45577526 |
| 18 | MP0002736_abnormal_nociception_after | 2.45141510 |
| 19 | MP0010329_abnormal_lipoprotein_level | 2.42627176 |
| 20 | MP0002419_abnormal_innate_immunity | 2.41941615 |
| 21 | MP0008260_abnormal_autophagy | 2.30396908 |
| 22 | MP0000569_abnormal_digit_pigmentation | 2.25320844 |
| 23 | MP0003172_abnormal_lysosome_physiology | 2.15635220 |
| 24 | MP0001666_abnormal_nutrient_absorption | 2.13006421 |
| 25 | MP0005083_abnormal_biliary_tract | 2.09819105 |
| 26 | MP0002733_abnormal_thermal_nociception | 2.08598406 |
| 27 | MP0001835_abnormal_antigen_presentation | 2.06577812 |
| 28 | MP0003183_abnormal_peptide_metabolism | 1.99296661 |
| 29 | MP0009785_altered_susceptibility_to | 1.95019002 |
| 30 | MP0002148_abnormal_hypersensitivity_rea | 1.94397534 |
| 31 | MP0003191_abnormal_cellular_cholesterol | 1.93716109 |
| 32 | MP0005025_abnormal_response_to | 1.92132964 |
| 33 | MP0003635_abnormal_synaptic_transmissio | 1.89359774 |
| 34 | MP0002998_abnormal_bone_remodeling | 1.88879091 |
| 35 | MP0001533_abnormal_skeleton_physiology | 1.85392727 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 1.79010582 |
| 37 | MP0002909_abnormal_adrenal_gland | 1.76601539 |
| 38 | MP0005000_abnormal_immune_tolerance | 1.76253776 |
| 39 | MP0009780_abnormal_chondrocyte_physiolo | 1.74955286 |
| 40 | MP0000604_amyloidosis | 1.70008552 |
| 41 | MP0005332_abnormal_amino_acid | 1.69648310 |
| 42 | MP0000343_altered_response_to | 1.69591941 |
| 43 | MP0001970_abnormal_pain_threshold | 1.68684664 |
| 44 | MP0003329_amyloid_beta_deposits | 1.68540378 |
| 45 | MP0000685_abnormal_immune_system | 1.64497243 |
| 46 | MP0009278_abnormal_bone_marrow | 1.63794103 |
| 47 | MP0010155_abnormal_intestine_physiology | 1.61328540 |
| 48 | MP0003828_pulmonary_edema | 1.61214474 |
| 49 | MP0009745_abnormal_behavioral_response | 1.57351268 |
| 50 | MP0001790_abnormal_immune_system | 1.57017454 |
| 51 | MP0005387_immune_system_phenotype | 1.57017454 |
| 52 | MP0005058_abnormal_lysosome_morphology | 1.56874250 |
| 53 | MP0002064_seizures | 1.55875583 |
| 54 | MP0008961_abnormal_basal_metabolism | 1.52166721 |
| 55 | MP0005409_darkened_coat_color | 1.51540512 |
| 56 | MP0005310_abnormal_salivary_gland | 1.50632784 |
| 57 | MP0002452_abnormal_antigen_presenting | 1.50508578 |
| 58 | MP0004947_skin_inflammation | 1.50419737 |
| 59 | MP0002063_abnormal_learning/memory/cond | 1.45890993 |
| 60 | MP0008438_abnormal_cutaneous_collagen | 1.44339901 |
| 61 | MP0004019_abnormal_vitamin_homeostasis | 1.42795412 |
| 62 | MP0000858_altered_metastatic_potential | 1.42718361 |
| 63 | MP0002118_abnormal_lipid_homeostasis | 1.42548278 |
| 64 | MP0005671_abnormal_response_to | 1.40529218 |
| 65 | MP0002723_abnormal_immune_serum | 1.39468984 |
| 66 | MP0001845_abnormal_inflammatory_respons | 1.38989760 |
| 67 | MP0001501_abnormal_sleep_pattern | 1.38360793 |
| 68 | MP0010386_abnormal_urinary_bladder | 1.37602557 |
| 69 | MP0003300_gastrointestinal_ulcer | 1.37009443 |
| 70 | MP0003448_altered_tumor_morphology | 1.35726491 |
| 71 | MP0009046_muscle_twitch | 1.35659089 |
| 72 | MP0000538_abnormal_urinary_bladder | 1.33631350 |
| 73 | MP0003868_abnormal_feces_composition | 1.32377681 |
| 74 | MP0003633_abnormal_nervous_system | 1.31656915 |
| 75 | MP0006276_abnormal_autonomic_nervous | 1.31118031 |
| 76 | MP0002572_abnormal_emotion/affect_behav | 1.30090431 |
| 77 | MP0001819_abnormal_immune_cell | 1.29703519 |
| 78 | MP0002420_abnormal_adaptive_immunity | 1.29348673 |
| 79 | MP0008469_abnormal_protein_level | 1.28152746 |
| 80 | MP0005397_hematopoietic_system_phenotyp | 1.26619559 |
| 81 | MP0001545_abnormal_hematopoietic_system | 1.26619559 |
| 82 | MP0008874_decreased_physiological_sensi | 1.26253750 |
| 83 | MP0003075_altered_response_to | 1.26172082 |
| 84 | MP0005535_abnormal_body_temperature | 1.23314766 |
| 85 | MP0008004_abnormal_stomach_pH | 1.22515663 |
| 86 | MP0001800_abnormal_humoral_immune | 1.22106044 |
| 87 | MP0004043_abnormal_pH_regulation | 1.21364290 |
| 88 | MP0003045_fibrosis | 1.20479855 |
| 89 | MP0003091_abnormal_cell_migration | 1.19771394 |
| 90 | MP0000920_abnormal_myelination | 1.19158037 |
| 91 | MP0002272_abnormal_nervous_system | 1.17583125 |
| 92 | MP0003566_abnormal_cell_adhesion | 1.17082303 |
| 93 | MP0003879_abnormal_hair_cell | 1.16051393 |
| 94 | MP0000609_abnormal_liver_physiology | 1.15957368 |
| 95 | MP0001440_abnormal_grooming_behavior | 1.15806437 |
| 96 | MP0003195_calcinosis | 1.15385723 |
| 97 | MP0002877_abnormal_melanocyte_morpholog | 1.14923724 |
| 98 | MP0002405_respiratory_system_inflammati | 1.13467864 |
| 99 | MP0000678_abnormal_parathyroid_gland | 1.12662492 |
| 100 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.12453491 |
| 101 | MP0010234_abnormal_vibrissa_follicle | 1.11244260 |
| 102 | MP0003453_abnormal_keratinocyte_physiol | 1.11183786 |
| 103 | MP0006054_spinal_hemorrhage | 1.11157072 |
| 104 | MP0003690_abnormal_glial_cell | 1.09487857 |
| 105 | MP0001958_emphysema | 1.07937653 |
| 106 | MP0003279_aneurysm | 1.06896463 |
| 107 | MP0001849_ear_inflammation | 1.06670865 |
| 108 | MP0009643_abnormal_urine_homeostasis | 1.05572326 |
| 109 | MP0005319_abnormal_enzyme/_coenzyme | 1.03013656 |
| 110 | MP0003656_abnormal_erythrocyte_physiolo | 1.02455597 |
| 111 | MP0002067_abnormal_sensory_capabilities | 1.01530828 |
| 112 | MP0005076_abnormal_cell_differentiation | 1.01179650 |
| 113 | MP0005257_abnormal_intraocular_pressure | 1.00487635 |
| 114 | MP0005464_abnormal_platelet_physiology | 1.00031222 |
| 115 | MP0001756_abnormal_urination | 0.99762668 |
| 116 | MP0004811_abnormal_neuron_physiology | 0.99286494 |
| 117 | MP0008872_abnormal_physiological_respon | 0.98946433 |
| 118 | MP0002896_abnormal_bone_mineralization | 0.98633071 |
| 119 | MP0003705_abnormal_hypodermis_morpholog | 0.98166718 |
| 120 | MP0001765_abnormal_ion_homeostasis | 0.96918504 |
| 121 | MP0009333_abnormal_splenocyte_physiolog | 0.95963126 |
| 122 | MP0004510_myositis | 0.92913717 |
| 123 | MP0002078_abnormal_glucose_homeostasis | 0.92427900 |
| 124 | MP0005167_abnormal_blood-brain_barrier | 0.91937987 |
| 125 | MP0003795_abnormal_bone_structure | 0.91599338 |
| 126 | MP0005390_skeleton_phenotype | 0.91008590 |
| 127 | MP0005164_abnormal_response_to | 0.89724208 |
| 128 | MP0005166_decreased_susceptibility_to | 0.88705972 |
| 129 | MP0003631_nervous_system_phenotype | 0.87780703 |
| 130 | MP0000716_abnormal_immune_system | 0.87443120 |
| 131 | MP0004130_abnormal_muscle_cell | 0.85537549 |
| 132 | MP0005448_abnormal_energy_balance | 0.85324094 |
| 133 | MP0004147_increased_porphyrin_level | 0.84878669 |
| 134 | MP0003303_peritoneal_inflammation | 0.84470924 |
| 135 | MP0002254_reproductive_system_inflammat | 0.83313469 |
| 136 | MP0001853_heart_inflammation | 0.82830626 |
| 137 | MP0001986_abnormal_taste_sensitivity | 0.81913745 |
| 138 | MP0001851_eye_inflammation | 0.81518125 |
| 139 | MP0008569_lethality_at_weaning | 0.81151965 |
| 140 | MP0010352_gastrointestinal_tract_polyps | 0.80143927 |
| 141 | MP0004883_abnormal_blood_vessel | 0.80001985 |
| 142 | MP0000490_abnormal_crypts_of | 0.78524904 |
| 143 | MP0003283_abnormal_digestive_organ | 0.78199841 |
| 144 | MP0005023_abnormal_wound_healing | 0.78145204 |
| 145 | MP0001486_abnormal_startle_reflex | 0.77602080 |
| 146 | MP0000465_gastrointestinal_hemorrhage | 0.75547660 |
| 147 | MP0005165_increased_susceptibility_to | 0.75037973 |
| 148 | MP0003634_abnormal_glial_cell | 0.74210952 |
| 149 | MP0002138_abnormal_hepatobiliary_system | 0.73911789 |
| 150 | MP0004924_abnormal_behavior | 0.72465096 |
| 151 | MP0005386_behavior/neurological_phenoty | 0.72465096 |
| 152 | MP0002928_abnormal_bile_duct | 0.71819695 |
| 153 | MP0002069_abnormal_eating/drinking_beha | 0.71813157 |
| 154 | MP0003953_abnormal_hormone_level | 0.70935244 |
| 155 | MP0002876_abnormal_thyroid_physiology | 0.69593679 |
| 156 | MP0000249_abnormal_blood_vessel | 0.69295776 |
| 157 | MP0000767_abnormal_smooth_muscle | 0.68248457 |
| 158 | MP0009642_abnormal_blood_homeostasis | 0.67868780 |
| 159 | MP0002557_abnormal_social/conspecific_i | 0.67243264 |
| 160 | MP0004264_abnormal_extraembryonic_tissu | 0.66976096 |
| 161 | MP0003638_abnormal_response/metabolism_ | 0.66776256 |
| 162 | MP0003866_abnormal_defecation | 0.65656312 |
| 163 | MP0002090_abnormal_vision | 0.64598084 |
| 164 | MP0009764_decreased_sensitivity_to | 0.64244775 |
| 165 | MP0001270_distended_abdomen | 0.64147298 |
| 166 | MP0000955_abnormal_spinal_cord | 0.63850431 |
| 167 | MP0005334_abnormal_fat_pad | 0.61896922 |
| 168 | MP0005636_abnormal_mineral_homeostasis | 0.61228804 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Vacuolated lymphocytes (HP:0001922) | 4.44239246 |
| 2 | Abnormality of macrophages (HP:0004311) | 4.33541569 |
| 3 | Eczematoid dermatitis (HP:0000976) | 4.24270232 |
| 4 | Recurrent abscess formation (HP:0002722) | 3.78577131 |
| 5 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.77799946 |
| 6 | Recurrent bacterial skin infections (HP:0005406) | 3.73874860 |
| 7 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.54446204 |
| 8 | Xanthomatosis (HP:0000991) | 3.50222930 |
| 9 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.49061217 |
| 10 | Myokymia (HP:0002411) | 3.47640236 |
| 11 | Deep venous thrombosis (HP:0002625) | 3.46118101 |
| 12 | Loss of speech (HP:0002371) | 3.44923759 |
| 13 | Disinhibition (HP:0000734) | 3.31093082 |
| 14 | Complement deficiency (HP:0004431) | 3.20018000 |
| 15 | Malnutrition (HP:0004395) | 3.17612355 |
| 16 | Action tremor (HP:0002345) | 3.17036675 |
| 17 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 3.08245722 |
| 18 | Neurofibrillary tangles (HP:0002185) | 3.08160838 |
| 19 | Intrahepatic cholestasis (HP:0001406) | 2.91783518 |
| 20 | Systemic lupus erythematosus (HP:0002725) | 2.90734499 |
| 21 | Conjugated hyperbilirubinemia (HP:0002908) | 2.88029277 |
| 22 | Focal seizures (HP:0007359) | 2.85375170 |
| 23 | Gingivitis (HP:0000230) | 2.84321177 |
| 24 | Spontaneous hematomas (HP:0007420) | 2.82077371 |
| 25 | Hypobetalipoproteinemia (HP:0003563) | 2.80909826 |
| 26 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.78139943 |
| 27 | Mucopolysacchariduria (HP:0008155) | 2.78139943 |
| 28 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.77823440 |
| 29 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.77823440 |
| 30 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.77823440 |
| 31 | Supranuclear gaze palsy (HP:0000605) | 2.73227640 |
| 32 | Focal motor seizures (HP:0011153) | 2.68838930 |
| 33 | Myocardial infarction (HP:0001658) | 2.65407692 |
| 34 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.62782332 |
| 35 | Abnormality of proline metabolism (HP:0010907) | 2.58095120 |
| 36 | Hydroxyprolinuria (HP:0003080) | 2.58095120 |
| 37 | Visual hallucinations (HP:0002367) | 2.57271008 |
| 38 | Ketosis (HP:0001946) | 2.53836261 |
| 39 | Dysostosis multiplex (HP:0000943) | 2.53130271 |
| 40 | Axonal loss (HP:0003447) | 2.49364397 |
| 41 | Ketoacidosis (HP:0001993) | 2.48243118 |
| 42 | Sensorimotor neuropathy (HP:0007141) | 2.48120430 |
| 43 | Epidermoid cyst (HP:0200040) | 2.46485309 |
| 44 | Orchitis (HP:0100796) | 2.46055907 |
| 45 | Joint hemorrhage (HP:0005261) | 2.45436463 |
| 46 | Myositis (HP:0100614) | 2.43020066 |
| 47 | Glomerulonephritis (HP:0000099) | 2.40176305 |
| 48 | Abnormality of the common coagulation pathway (HP:0010990) | 2.39739571 |
| 49 | Upper motor neuron abnormality (HP:0002127) | 2.37819709 |
| 50 | Prolonged partial thromboplastin time (HP:0003645) | 2.37102310 |
| 51 | Cerebral aneurysm (HP:0004944) | 2.35077874 |
| 52 | Gout (HP:0001997) | 2.33515934 |
| 53 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.33431459 |
| 54 | Apathy (HP:0000741) | 2.32654859 |
| 55 | Abnormality of the lower motor neuron (HP:0002366) | 2.31736138 |
| 56 | Mediastinal lymphadenopathy (HP:0100721) | 2.30223864 |
| 57 | Abnormality of complement system (HP:0005339) | 2.27754971 |
| 58 | Diminished motivation (HP:0000745) | 2.25100178 |
| 59 | Status epilepticus (HP:0002133) | 2.25093519 |
| 60 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.24398313 |
| 61 | Thin bony cortex (HP:0002753) | 2.22744391 |
| 62 | Increased cerebral lipofuscin (HP:0011813) | 2.22325333 |
| 63 | Abnormality of purine metabolism (HP:0004352) | 2.20502483 |
| 64 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.19600974 |
| 65 | Hypercholesterolemia (HP:0003124) | 2.18948017 |
| 66 | Recurrent skin infections (HP:0001581) | 2.18263419 |
| 67 | Generalized tonic-clonic seizures (HP:0002069) | 2.17042830 |
| 68 | Asymmetric septal hypertrophy (HP:0001670) | 2.14194539 |
| 69 | Vertebral compression fractures (HP:0002953) | 2.14144827 |
| 70 | Obstructive lung disease (HP:0006536) | 2.13670096 |
| 71 | Chronic obstructive pulmonary disease (HP:0006510) | 2.13670096 |
| 72 | Pathologic fracture (HP:0002756) | 2.13413242 |
| 73 | Febrile seizures (HP:0002373) | 2.13005286 |
| 74 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 2.12773872 |
| 75 | Atonic seizures (HP:0010819) | 2.12143383 |
| 76 | Fat malabsorption (HP:0002630) | 2.12098830 |
| 77 | Postural instability (HP:0002172) | 2.11343395 |
| 78 | Bone pain (HP:0002653) | 2.11319091 |
| 79 | Skin nodule (HP:0200036) | 2.09875717 |
| 80 | Neuronal loss in central nervous system (HP:0002529) | 2.09393307 |
| 81 | Hyperammonemia (HP:0001987) | 2.09129644 |
| 82 | Absence seizures (HP:0002121) | 2.08225681 |
| 83 | Global brain atrophy (HP:0002283) | 2.07211642 |
| 84 | Insidious onset (HP:0003587) | 2.06641246 |
| 85 | Termporal pattern (HP:0011008) | 2.06641246 |
| 86 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.06345348 |
| 87 | Mitral stenosis (HP:0001718) | 2.05946372 |
| 88 | Autoimmune thrombocytopenia (HP:0001973) | 2.05575191 |
| 89 | Impaired social interactions (HP:0000735) | 2.05163164 |
| 90 | Abnormal social behavior (HP:0012433) | 2.05163164 |
| 91 | Hyperactive renin-angiotensin system (HP:0000841) | 2.04400611 |
| 92 | Hypolipoproteinemia (HP:0010981) | 2.03754728 |
| 93 | Pheochromocytoma (HP:0002666) | 2.03643300 |
| 94 | Nuclear cataract (HP:0100018) | 2.03642716 |
| 95 | Polycythemia (HP:0001901) | 2.02560944 |
| 96 | Hyperglycinuria (HP:0003108) | 2.01727875 |
| 97 | Postural tremor (HP:0002174) | 2.01624566 |
| 98 | Retinal atrophy (HP:0001105) | 2.01522293 |
| 99 | Hyperlipoproteinemia (HP:0010980) | 2.01505032 |
| 100 | Neonatal onset (HP:0003623) | 2.00555189 |
| 101 | Cellulitis (HP:0100658) | 1.99115891 |
| 102 | Hand muscle atrophy (HP:0009130) | 1.98913944 |
| 103 | Facial shape deformation (HP:0011334) | 1.96542325 |
| 104 | Potter facies (HP:0002009) | 1.96542325 |
| 105 | Hematochezia (HP:0002573) | 1.96448895 |
| 106 | Impaired pain sensation (HP:0007328) | 1.95507346 |
| 107 | Abnormality of pain sensation (HP:0010832) | 1.95507346 |
| 108 | Peripheral demyelination (HP:0011096) | 1.94856361 |
| 109 | Optic neuritis (HP:0100653) | 1.94577667 |
| 110 | Retrobulbar optic neuritis (HP:0100654) | 1.94577667 |
| 111 | Increased CSF protein (HP:0002922) | 1.93996777 |
| 112 | Papilledema (HP:0001085) | 1.93259445 |
| 113 | Progressive cerebellar ataxia (HP:0002073) | 1.92793950 |
| 114 | Metaphyseal irregularity (HP:0003025) | 1.92650009 |
| 115 | Dementia (HP:0000726) | 1.90878028 |
| 116 | Amyloidosis (HP:0011034) | 1.90725521 |
| 117 | Increased serum ferritin (HP:0003281) | 1.90253185 |
| 118 | Osteolytic defects of the hand bones (HP:0009699) | 1.89930756 |
| 119 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.89930756 |
| 120 | Abnormality of nucleobase metabolism (HP:0010932) | 1.89589570 |
| 121 | Recurrent gram-negative bacterial infections (HP:0005420) | 1.89497597 |
| 122 | Ulnar claw (HP:0001178) | 1.88536463 |
| 123 | Hypercortisolism (HP:0001578) | 1.88534766 |
| 124 | Agitation (HP:0000713) | 1.88198794 |
| 125 | Dialeptic seizures (HP:0011146) | 1.87928816 |
| 126 | Purpura (HP:0000979) | 1.86577490 |
| 127 | Urinary bladder sphincter dysfunction (HP:0002839) | 1.85155255 |
| 128 | Torticollis (HP:0000473) | 1.84319224 |
| 129 | Cerebral inclusion bodies (HP:0100314) | 1.83812023 |
| 130 | Urticaria (HP:0001025) | 1.83650616 |
| 131 | Alkalosis (HP:0001948) | 1.81911094 |
| 132 | Progressive visual loss (HP:0000529) | 1.81719479 |
| 133 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 1.81190445 |
| 134 | Peritonitis (HP:0002586) | 1.81090058 |
| 135 | Petechiae (HP:0000967) | 1.80880968 |
| 136 | Nephritis (HP:0000123) | 1.80378723 |
| 137 | Acanthocytosis (HP:0001927) | 1.80339255 |
| 138 | Personality changes (HP:0000751) | 1.80310117 |
| 139 | Hepatosplenomegaly (HP:0001433) | 1.79691928 |
| 140 | Mutism (HP:0002300) | 1.79669754 |
| 141 | Hyperparathyroidism (HP:0000843) | 1.79637896 |
| 142 | Recurrent fungal infections (HP:0002841) | 1.79635329 |
| 143 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.79530979 |
| 144 | Depression (HP:0000716) | 1.78873244 |
| 145 | Cardiomegaly (HP:0001640) | 1.76531454 |
| 146 | Progressive neurologic deterioration (HP:0002344) | 1.75252409 |
| 147 | Gastrointestinal infarctions (HP:0005244) | 1.75132688 |
| 148 | Tetraparesis (HP:0002273) | 1.75013491 |
| 149 | Protuberant abdomen (HP:0001538) | 1.74806780 |
| 150 | Inappropriate behavior (HP:0000719) | 1.73805157 |
| 151 | Hypoglycemic coma (HP:0001325) | 1.73780358 |
| 152 | Premature loss of primary teeth (HP:0006323) | 1.73415810 |
| 153 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.72958241 |
| 154 | Abnormality of glycine metabolism (HP:0010895) | 1.72958241 |
| 155 | Abnormal eating behavior (HP:0100738) | 1.71984743 |
| 156 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.71953448 |
| 157 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.71953448 |
| 158 | Abnormality of glycolipid metabolism (HP:0010969) | 1.71953448 |
| 159 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.71739632 |
| 160 | Osteomyelitis (HP:0002754) | 1.70878808 |
| 161 | Distal upper limb amyotrophy (HP:0007149) | 1.70567354 |
| 162 | Pulmonary infiltrates (HP:0002113) | 1.69160699 |
| 163 | Agnosia (HP:0010524) | 1.68263543 |
| 164 | Hypophosphatemia (HP:0002148) | 1.68241412 |
| 165 | Hemorrhage of the eye (HP:0011885) | 1.67804403 |
| 166 | Flat acetabular roof (HP:0003180) | 1.66164909 |
| 167 | Pustule (HP:0200039) | 1.66011734 |
| 168 | Slow saccadic eye movements (HP:0000514) | 1.65412910 |
| 169 | Spondylolisthesis (HP:0003302) | 1.65259857 |
| 170 | Abnormality of iron homeostasis (HP:0011031) | 1.64290759 |
| 171 | Chronic diarrhea (HP:0002028) | 1.62955176 |
| 172 | Thoracic kyphosis (HP:0002942) | 1.62793723 |
| 173 | Abdominal distention (HP:0003270) | 1.62682697 |
| 174 | Hemoptysis (HP:0002105) | 1.61724608 |
| 175 | Aneurysm (HP:0002617) | 1.61423884 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP3K9 | 3.13369242 |
| 2 | RIPK4 | 3.03478925 |
| 3 | NTRK1 | 2.91986511 |
| 4 | NTRK3 | 2.72193752 |
| 5 | BLK | 2.72075607 |
| 6 | KSR2 | 2.60732572 |
| 7 | MAP3K2 | 2.51312301 |
| 8 | IRAK3 | 2.40673879 |
| 9 | MAP2K3 | 2.38185713 |
| 10 | MAP3K3 | 2.17362360 |
| 11 | DAPK2 | 2.17024160 |
| 12 | MAP2K4 | 2.13566234 |
| 13 | ERN1 | 2.12482114 |
| 14 | MAP3K4 | 2.04540161 |
| 15 | ACVR1B | 2.03974058 |
| 16 | SIK2 | 1.96916691 |
| 17 | RIPK1 | 1.91518677 |
| 18 | DDR2 | 1.86368869 |
| 19 | GRK5 | 1.75800799 |
| 20 | MINK1 | 1.74471442 |
| 21 | CSK | 1.73215693 |
| 22 | LMTK2 | 1.72944353 |
| 23 | RET | 1.70379343 |
| 24 | MAP3K14 | 1.66959551 |
| 25 | CAMKK1 | 1.66914892 |
| 26 | FRK | 1.64975534 |
| 27 | MAP3K11 | 1.60604990 |
| 28 | SIK1 | 1.58576243 |
| 29 | TAOK3 | 1.58531642 |
| 30 | IRAK4 | 1.57920783 |
| 31 | FGR | 1.56068494 |
| 32 | TAOK2 | 1.55251644 |
| 33 | PAK6 | 1.50276697 |
| 34 | TRIB3 | 1.47992187 |
| 35 | ZAP70 | 1.47605127 |
| 36 | EPHA4 | 1.41155065 |
| 37 | SGK3 | 1.37351007 |
| 38 | MATK | 1.32542197 |
| 39 | CAMK1G | 1.32170047 |
| 40 | MAP2K7 | 1.28960177 |
| 41 | STK38 | 1.28639928 |
| 42 | MAP3K1 | 1.26980145 |
| 43 | PKN2 | 1.25531480 |
| 44 | TBK1 | 1.22177700 |
| 45 | MAP3K13 | 1.21383850 |
| 46 | FGFR4 | 1.17012627 |
| 47 | MAP4K1 | 1.15903808 |
| 48 | TESK2 | 1.14720126 |
| 49 | INSRR | 1.14496504 |
| 50 | MAP3K7 | 1.13693462 |
| 51 | SCYL2 | 1.11178173 |
| 52 | SGK2 | 1.10727801 |
| 53 | CDK12 | 1.08296634 |
| 54 | JAK1 | 1.05842126 |
| 55 | GRK6 | 1.05483597 |
| 56 | PRKD2 | 1.04365430 |
| 57 | PTK6 | 1.03145213 |
| 58 | SGK223 | 1.01366204 |
| 59 | SGK494 | 1.01366204 |
| 60 | CAMKK2 | 1.00417801 |
| 61 | TESK1 | 0.98016960 |
| 62 | CSF1R | 0.95542358 |
| 63 | PRKD3 | 0.95291248 |
| 64 | FES | 0.95095919 |
| 65 | JAK2 | 0.95071984 |
| 66 | ARAF | 0.94973048 |
| 67 | RPS6KA2 | 0.94581790 |
| 68 | JAK3 | 0.94562293 |
| 69 | MAP2K1 | 0.92430777 |
| 70 | PTK2 | 0.91697934 |
| 71 | CAMK1D | 0.91497658 |
| 72 | SMG1 | 0.90326469 |
| 73 | PRKCH | 0.89665588 |
| 74 | MAP3K12 | 0.86577661 |
| 75 | GRK7 | 0.86066495 |
| 76 | PAK4 | 0.85318613 |
| 77 | MAP3K6 | 0.84668790 |
| 78 | WNK1 | 0.84556925 |
| 79 | PDPK1 | 0.84382994 |
| 80 | CDK5 | 0.84257117 |
| 81 | DAPK1 | 0.83690441 |
| 82 | EPHB1 | 0.83201993 |
| 83 | ABL2 | 0.82842871 |
| 84 | PDK1 | 0.82394389 |
| 85 | TAOK1 | 0.82368862 |
| 86 | IRAK2 | 0.81907268 |
| 87 | NME2 | 0.81352234 |
| 88 | HCK | 0.77310139 |
| 89 | CDK6 | 0.75765379 |
| 90 | SYK | 0.74639501 |
| 91 | WNK4 | 0.72412148 |
| 92 | TTN | 0.72120343 |
| 93 | PRKG2 | 0.71380379 |
| 94 | FGFR3 | 0.69362007 |
| 95 | CAMK4 | 0.67583508 |
| 96 | KSR1 | 0.67548262 |
| 97 | SIK3 | 0.66940522 |
| 98 | YES1 | 0.66114092 |
| 99 | MAPK12 | 0.65641868 |
| 100 | MOS | 0.65593753 |
| 101 | LYN | 0.64088864 |
| 102 | ALK | 0.62684275 |
| 103 | NTRK2 | 0.61398430 |
| 104 | STK11 | 0.60909590 |
| 105 | ERBB2 | 0.60894799 |
| 106 | PRKCG | 0.60385724 |
| 107 | PDK2 | 0.59239945 |
| 108 | NEK9 | 0.59156395 |
| 109 | LATS2 | 0.59101885 |
| 110 | PRKCZ | 0.58408441 |
| 111 | IKBKE | 0.57684791 |
| 112 | PDGFRB | 0.56457762 |
| 113 | RPS6KL1 | 0.56419701 |
| 114 | RPS6KC1 | 0.56419701 |
| 115 | MST1R | 0.55113032 |
| 116 | TGFBR2 | 0.52548015 |
| 117 | MAP2K2 | 0.52252420 |
| 118 | PTK2B | 0.51730374 |
| 119 | MAP3K5 | 0.51374617 |
| 120 | MARK1 | 0.50869070 |
| 121 | PDGFRA | 0.50597833 |
| 122 | CDC42BPA | 0.48379288 |
| 123 | MAPK15 | 0.47553454 |
| 124 | CAMK1 | 0.46656780 |
| 125 | SGK1 | 0.46225431 |
| 126 | MAPK7 | 0.46100095 |
| 127 | MARK2 | 0.45906326 |
| 128 | MAP3K8 | 0.44452437 |
| 129 | HIPK2 | 0.44413918 |
| 130 | MAPK11 | 0.44072599 |
| 131 | PRPF4B | 0.43871370 |
| 132 | BTK | 0.43816491 |
| 133 | TYK2 | 0.43454206 |
| 134 | PRKAA1 | 0.43306770 |
| 135 | LCK | 0.43183467 |
| 136 | FYN | 0.43104679 |
| 137 | PRKACG | 0.41807162 |
| 138 | IKBKB | 0.41197020 |
| 139 | KIT | 0.41062389 |
| 140 | BMX | 0.40599055 |
| 141 | PINK1 | 0.39357487 |
| 142 | PRKAA2 | 0.39300934 |
| 143 | TNK2 | 0.38643814 |
| 144 | RAF1 | 0.38396015 |
| 145 | FER | 0.37766260 |
| 146 | RPS6KA6 | 0.36378257 |
| 147 | IRAK1 | 0.35541676 |
| 148 | SRC | 0.35453203 |
| 149 | BMPR2 | 0.35339934 |
| 150 | MARK3 | 0.35297718 |
| 151 | MAP2K6 | 0.33915844 |
| 152 | ICK | 0.32461515 |
| 153 | CAMK2A | 0.32279551 |
| 154 | CSNK1G2 | 0.32277136 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Other glycan degradation_Homo sapiens_hsa00511 | 3.53007721 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.54483411 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.23566672 |
| 4 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 2.23273553 |
| 5 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.10991029 |
| 6 | Leishmaniasis_Homo sapiens_hsa05140 | 2.10623906 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.06831377 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.02230815 |
| 9 | Bile secretion_Homo sapiens_hsa04976 | 1.98534850 |
| 10 | Tuberculosis_Homo sapiens_hsa05152 | 1.90113932 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.87588928 |
| 12 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.78999992 |
| 13 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.67846014 |
| 14 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.64346787 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.63378532 |
| 16 | Phagosome_Homo sapiens_hsa04145 | 1.52904187 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.50348340 |
| 18 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.48738894 |
| 19 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.45377992 |
| 20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.36729670 |
| 21 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.35943065 |
| 22 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.35673398 |
| 23 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.33554874 |
| 24 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.32435128 |
| 25 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.31966439 |
| 26 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.31741352 |
| 27 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30998892 |
| 28 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.30319584 |
| 29 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.29124208 |
| 30 | Pertussis_Homo sapiens_hsa05133 | 1.29115340 |
| 31 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.26386300 |
| 32 | Insulin secretion_Homo sapiens_hsa04911 | 1.23966838 |
| 33 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22197033 |
| 34 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.20408872 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.17692337 |
| 36 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.17338750 |
| 37 | Histidine metabolism_Homo sapiens_hsa00340 | 1.16956488 |
| 38 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.16885753 |
| 39 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.14917032 |
| 40 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.14839437 |
| 41 | Mineral absorption_Homo sapiens_hsa04978 | 1.14437304 |
| 42 | Salmonella infection_Homo sapiens_hsa05132 | 1.14412507 |
| 43 | Amoebiasis_Homo sapiens_hsa05146 | 1.11968190 |
| 44 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.11663360 |
| 45 | ABC transporters_Homo sapiens_hsa02010 | 1.07898300 |
| 46 | Salivary secretion_Homo sapiens_hsa04970 | 1.05642981 |
| 47 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.01580272 |
| 48 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.01277238 |
| 49 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.01086811 |
| 50 | Allograft rejection_Homo sapiens_hsa05330 | 1.00735095 |
| 51 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.00539385 |
| 52 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.99517862 |
| 53 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.99413885 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 0.98152920 |
| 55 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.98124427 |
| 56 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.97122210 |
| 57 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.95660365 |
| 58 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.95240743 |
| 59 | Long-term potentiation_Homo sapiens_hsa04720 | 0.95068524 |
| 60 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.94027654 |
| 61 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.93874727 |
| 62 | Circadian entrainment_Homo sapiens_hsa04713 | 0.93480750 |
| 63 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93440819 |
| 64 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.93158873 |
| 65 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.91772338 |
| 66 | Legionellosis_Homo sapiens_hsa05134 | 0.91331435 |
| 67 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.91141552 |
| 68 | Asthma_Homo sapiens_hsa05310 | 0.90750166 |
| 69 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.90725985 |
| 70 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.90402594 |
| 71 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.89649794 |
| 72 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.89550597 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.89443161 |
| 74 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.89331844 |
| 75 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.89096969 |
| 76 | Olfactory transduction_Homo sapiens_hsa04740 | 0.88433061 |
| 77 | Hepatitis C_Homo sapiens_hsa05160 | 0.88360882 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.88272909 |
| 79 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.86912710 |
| 80 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.86612417 |
| 81 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.86055766 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.85649569 |
| 83 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.84944217 |
| 84 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.84779820 |
| 85 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83567356 |
| 86 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.83498734 |
| 87 | GABAergic synapse_Homo sapiens_hsa04727 | 0.83386020 |
| 88 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.83278841 |
| 89 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.83076508 |
| 90 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.82871977 |
| 91 | Dopaminergic synapse_Homo sapiens_hsa04728 | 0.82286982 |
| 92 | Nicotine addiction_Homo sapiens_hsa05033 | 0.81898902 |
| 93 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.80817465 |
| 94 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.80643957 |
| 95 | Hepatitis B_Homo sapiens_hsa05161 | 0.80237061 |
| 96 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.79969381 |
| 97 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.79722862 |
| 98 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.79609658 |
| 99 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.79267006 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.78826368 |
| 101 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.78783938 |
| 102 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78765424 |
| 103 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.78131331 |
| 104 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.76411366 |
| 105 | Peroxisome_Homo sapiens_hsa04146 | 0.76332480 |
| 106 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.76262387 |
| 107 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.76125147 |
| 108 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.75670242 |
| 109 | Shigellosis_Homo sapiens_hsa05131 | 0.74968167 |
| 110 | Lysosome_Homo sapiens_hsa04142 | 0.74854726 |
| 111 | Endocytosis_Homo sapiens_hsa04144 | 0.73924217 |
| 112 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.73567712 |
| 113 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.73536570 |
| 114 | * Protein digestion and absorption_Homo sapiens_hsa04974 | 0.73447426 |
| 115 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.72891103 |
| 116 | Renin secretion_Homo sapiens_hsa04924 | 0.72025984 |
| 117 | Viral myocarditis_Homo sapiens_hsa05416 | 0.70787072 |
| 118 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.70777690 |
| 119 | Apoptosis_Homo sapiens_hsa04210 | 0.70758305 |
| 120 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.70130855 |
| 121 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.70127610 |
| 122 | Platelet activation_Homo sapiens_hsa04611 | 0.69505328 |
| 123 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.69098808 |
| 124 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.68716356 |
| 125 | Morphine addiction_Homo sapiens_hsa05032 | 0.68630397 |
| 126 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.67992746 |
| 127 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.66601372 |
| 128 | Cocaine addiction_Homo sapiens_hsa05030 | 0.66040558 |
| 129 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.65901628 |
| 130 | Taste transduction_Homo sapiens_hsa04742 | 0.65862751 |
| 131 | Insulin resistance_Homo sapiens_hsa04931 | 0.65497131 |
| 132 | Galactose metabolism_Homo sapiens_hsa00052 | 0.64714034 |
| 133 | Long-term depression_Homo sapiens_hsa04730 | 0.64351969 |
| 134 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.62966808 |
| 135 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.60970232 |
| 136 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.60688291 |
| 137 | Glioma_Homo sapiens_hsa05214 | 0.60596608 |
| 138 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.59278847 |
| 139 | Lysine degradation_Homo sapiens_hsa00310 | 0.58685190 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.57258606 |
| 141 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56654513 |
| 142 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.54767131 |
| 143 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.54597285 |
| 144 | Measles_Homo sapiens_hsa05162 | 0.53866918 |
| 145 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.53341620 |
| 146 | Endometrial cancer_Homo sapiens_hsa05213 | 0.52886760 |
| 147 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.52795000 |
| 148 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.52413500 |
| 149 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51729935 |
| 150 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.51552619 |
| 151 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.51421807 |
| 152 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.50615332 |
| 153 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50202387 |
| 154 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.49668656 |
| 155 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.48591459 |
| 156 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.48578379 |
| 157 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.48015994 |
| 158 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.47887926 |
| 159 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.47407095 |
| 160 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.46431413 |
| 161 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45614953 |
| 162 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45585014 |
| 163 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43716745 |
| 164 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.43370786 |
| 165 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.42641619 |
| 166 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.42274479 |
| 167 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.42258780 |
| 168 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.41550393 |

